Welcome to LookChem.com Sign In|Join Free

CAS

  • or
METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE, an organic compound with the chemical formula C9H15NO2, is a derivative of amino acids characterized by a unique seven-membered cycloheptane ring structure, a methyl group attached to the amino group, and a carboxylate group. It is synthesized through organic reactions and serves as a valuable building block in the pharmaceutical industry for the synthesis of various compounds, including drugs.

183429-63-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 183429-63-2 Structure
  • Basic information

    1. Product Name: METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE
    2. Synonyms: METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE;Methyl 1-amino-1-cycloheptanecarboxylate HCl;Methyl 1-aMinocycloheptanecarboxylate;Cycloheptanecarboxylic acid, 1-amino-, methyl ester
    3. CAS NO:183429-63-2
    4. Molecular Formula: C9H17NO2
    5. Molecular Weight: 171.24
    6. EINECS: N/A
    7. Product Categories: pharmacetical
    8. Mol File: 183429-63-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 231.9 °C at 760 mmHg
    3. Flash Point: 98.6 °C
    4. Appearance: /
    5. Density: 1.02 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE(CAS DataBase Reference)
    10. NIST Chemistry Reference: METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE(183429-63-2)
    11. EPA Substance Registry System: METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE(183429-63-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 183429-63-2(Hazardous Substances Data)

183429-63-2 Usage

Uses

Used in Pharmaceutical Industry:
METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE is used as a building block for the synthesis of various compounds, including drugs, due to its unique structural features and reactivity in organic reactions. Its cycloheptane ring and functional groups contribute to the development of new drugs and pharmaceuticals with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE is employed as a key intermediate in the synthesis of bioactive molecules and drug candidates. Its structural properties allow for the creation of diverse chemical entities with potential therapeutic effects, making it a valuable component in drug discovery and development processes.

Check Digit Verification of cas no

The CAS Registry Mumber 183429-63-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,4,2 and 9 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 183429-63:
(8*1)+(7*8)+(6*3)+(5*4)+(4*2)+(3*9)+(2*6)+(1*3)=152
152 % 10 = 2
So 183429-63-2 is a valid CAS Registry Number.

183429-63-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name METHYL 1-AMINO-1-CYCLOHEPTANECARBOXYLATE

1.2 Other means of identification

Product number -
Other names Methyl 1-amino-1-cycloheptanecarboxylate HCl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:183429-63-2 SDS

183429-63-2Downstream Products

183429-63-2Relevant articles and documents

Polycyclic Azetidines and Pyrrolidines via Palladium-Catalyzed Intramolecular Amination of Unactivated C(sp3)-H Bonds

Zhao, Jie,Zhao, Xiao-Jing,Cao, Pei,Liu, Ji-Kai,Wu, Bin

supporting information, p. 4880 - 4883 (2017/09/23)

A novel strategy to construct complex polycyclic nitrogen-containing heterocycles from aliphatic amines via picolinamide-assisted palladium-catalyzed C-H bond activation reaction was reported. The reaction exhibits broad substrate scope for the synthesis of various azabicyclic scaffolds, including azetidines and tropane-class alkaloids. Application of this method to naturally occurring (-)-cis-myrtanylamine, an unprecedented type of carbon-carbon bond activation, in which the electron-pair involved initiates an intramolecular "SN2-like" displacement of a cyclopalladium-fragment from a tertiary center, is described.

Design and Synthesis of Fsp3-Rich, Bis-Spirocyclic-Based Compound Libraries for Biological Screening

Stotani, Silvia,Lorenz, Christoph,Winkler, Matthias,Medda, Federico,Picazo, Edwige,Ortega Martinez, Raquel,Karawajczyk, Anna,Sanchez-Quesada, Jorge,Giordanetto, Fabrizio

, p. 330 - 336 (2016/07/06)

The exploration of innovative chemical space is a critical step in the early phases of drug discovery. Bis-spirocyclic frameworks occur in natural products and other biologically relevant metabolites and show attractive features, such as molecular compactness, structural complexity, and three-dimensional character. A concise approach to the synthesis of bis-spirocyclic-based compound libraries starting from readily available commercial reagents and robust chemical transformations has been developed. A number of novel bis-spirocyclic scaffold examples, as implemented in the European Lead Factory project, is presented.

Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups

Sparks, Steven M.,Banker, Pierette,Bickett, David M.,Carter, H. Luke,Clancy, Daphne C.,Dickerson, Scott H.,Dwornik, Kate A.,Garrido, Dulce M.,Golden, Pamela L.,Nolte, Robert T.,Peat, Andrew J.,Sheckler, Lauren R.,Tavares, Francis X.,Thomson, Stephen A.,Wang, Liping,Weiel, James E.

scheme or table, p. 976 - 980 (2009/09/25)

Optimization of the amino acid residue within a series of anthranilimide-based glycogen phosphorylase inhibitors is described. These studies culminated in the identification of anthranilimides 16 and 22 which displayed potent in vitro inhibition of GPa in

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 183429-63-2